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Endovascular management and the risk of late failure in the
treatment of ureteroarterial ﬁstulas
George Titomihelakis, MS, Anthony Feghali, MD, Tuong Nguyen, MD, Dawn Salvatore, MD, FACS,
Paul DiMuzio, MD, FACS, and Babak Abai, MD, FACS, Philadelphia, Pa

ABSTRACT
Ureteroarterial ﬁstula (UAF) is a rare and life-threatening source of hematuria. A high index of suspicion is warranted for
early diagnosis and timely intervention. Because of high perioperative risk and comorbidities in UAF patients, the
endovascular approach has become preferred for repair. Infection can complicate this mode of therapy, and treatment
with antibiotics is important. Herein we present ﬁve cases of secondary UAFs treated with stent graft alone or stent graft
and embolization. (J Vasc Surg Cases and Innovative Techniques 2019;5:396-401.)
Keywords: Ureteroarterial ﬁstula; Hematuria; Stent graft; Endovascular therapy

Ureteroarterial ﬁstulas (UAFs) are a rare life-threatening
source of hematuria caused by inﬂammatory ﬁbrocystic
changes leading to pathologic communication between
ureters and adjacent iliac arteries (Fig 1, A). They are associated with pelvic irradiation, malignant disease, and
pelvic-abdominal surgery and are classiﬁed into primary
(15%) and secondary (85%) lesions. Primary ﬁstulas are
seen with aortoiliac aneurysmal disease; secondary ﬁstulas occur after pelvic surgery, ureteral stenting, or
vascular surgery.1,2 Traditionally, open surgical techniques
involving ligation of the artery and suturing with a patch
graft along with urinary diversion, nephrostomy, or nephrectomy3 have been used to treat UAF.4 Iliac artery
embolization with bypass5 and transrenal ureteral occlusion with Gianturco coils6 are also options. Endovascular
procedures have become an alternative to open surgery,
given the less invasive nature and complicated anatomic
presentation in most patients secondary to previous comorbidity7 (Fig 1, B). There is, however, still concern for
infection in patients who are treated with an endovascular approach. In addition, long-term outcomes have
included recurrence of hematuria in the ﬁrst and second
year after stent graft placement, with increased recurrence rate in the second year.8 Mortality rates attributed
to UAF are between 10% and 13%, and 22% mortality is
associated with hemodynamic instability.9 Here we
describe and review ﬁve cases of endovascular repair
(Table). The patients described herein have given

appropriate consent to have their case details and images included in this case report.

CASE REPORTS
Case 1. A 70-year-old woman with a history of cervical cancer,
total hysterectomy, and external beam radiotherapy requiring
chronic bilateral ureteral stenting had a right UAF treated
7 years previous to this presentation with coil embolization of
the right internal iliac artery and stent graft from the common
iliac to external iliac artery; she was taking oral ciproﬂoxacin for
lifelong urinary tract infection (UTI) prophylaxis. Gross hematuria
ensued during removal of the left ureteral stent, raising suspicion for a UAF. Ureteroscopy showed pulsatile bleeding below
the pelvic brim, and a balloon was inﬂated in the ureter to
tamponade the bleed. Selective arteriography of the left
external iliac artery with the balloon temporarily deﬂated
showed extravasation of contrast material into the ureter.
Intravenous ciproﬂoxacin and vancomycin were administered
preoperatively, followed by deployment of an 8-  50-mm Viabahn stent graft (W. L. Gore & Associates, Newark, Del), and
follow-up arteriography showed no bleeding in the ureter (Fig 2).
The patient was lost to follow-up.

Case 2. A 77-year-old woman with a history of uterine cancer
treated 20 years ago with hysterectomy, irradiation, and chronic
bilateral ureteral stents developed hematuria during a ureteral
stent change. Abdominal and iliac arteriograms were obtained
and identiﬁed a communication between the right internal
iliac artery and right ureter. The patient was successfully
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iliac artery. Hematuria resolved after endograft placement. The
patient had received a 4-week course of ertapenem before the
operation for Klebsiella UTI, and a 14-day treatment of daptomycin and ﬂuconazole was prescribed for Enterococcus faecalis
and Candida infection that had developed postoperatively. The
patient was discharged but died a year later of complications of
renal failure. There was no recurrent bleeding, and renal failure
was not related to the treatment.
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Fig 1. A, Ureteroarterial ﬁstula (UAF) formed between the left common iliac artery and the left ureter with blood
ﬂowing into the ureter. B, Stent graft placement stopping blood ﬂow into the ureter.

Case 3. A 58-year-old woman with a history of external beam

suppression with lifelong trimethoprim-sulfamethoxazole. The

irradiation for cervical cancer 11 years earlier with bilateral

decision to leave the infected stent graft and to prescribe the

double-J stents presented with gross hematuria after having a

patient lifelong antibiotics was made with consideration of the

blood transfusion and bladder irrigation for a similar complaint.

patient’s wishes and consultation with the urology and infectious

Cystoscopy revealed blood oozing from the right ureteral oriﬁce,
and subsequent ﬂexible ureteroscopy showed pulsatile

disease services. The patient was asymptomatic and without

bleeding at the site of the iliac artery. Angiography conﬁrmed
the UAF, which was successfully treated with a 5-  22-mm
Atrium iCast stent graft (Atrium Medical Corporation, Hudson,
NH) deployed in the right internal iliac artery. Hematuria
resolved after placement of the stent graft, and the patient
remained asymptomatic without recurrence at both 1-month
and 10-month follow-up.

hematuria at 7-month follow-up (Fig 3).

Case 5. A 56-year-old man with a history of colorectal cancer
stage III, resection, chemotherapy, and radiation therapy presented with complications secondary to bleeding from the left
internal iliac artery. Signiﬁcant hematuria was present through a
urostomy into an ileal conduit placed in the past; he had
undergone stent graft placement in the left iliac arterial system
along with coil embolization of the left internal iliac artery.

Case 4. A 58-year-old woman with a history of ovarian and

Ampicillin was administered for 14 days starting 24 hours before

rectal carcinoma with chemoradiation, total hysterectomy with

surgery. Two months after coil embolization, the patient had an

bilateral salpingo-oophorectomy, and proctectomy with chronic
indwelling resonance stents presented with gross hematuria.

infection and underwent combined endovascular and open
surgical repair with a right common femoral to left common

Retrograde pyelography revealed a right UAF from the right iliac

femoral artery bypass with reverse great saphenous vein. An

artery to the right ureter; a 9-mm  10-cm Viabahn stent graft

Amplatzer plug (Abbott, St. Paul, Minn) was placed in the

was successfully placed in the right common iliac to the external

proximal common iliac artery, and the distal external iliac artery

iliac artery to cover the ﬁstula, and hematuria stopped. The
patient was originally treated for chronic pyelonephritis with

was ligated. The patient had bleeding internally 3 months later,

anidulafungin (Eraxis) for Candida krusei infection for 14 days and

patient’s family decided to institute comfort care measures

was

secondary to his deconditioned state and advanced stage of his
cancer, and the patient died (Fig 4).

also

prescribed

7

days

of

oral

trimethoprim-

sulfamethoxazole (Bactrim). She received clindamycin preoper-

and angiography showed common iliac stump blowout. The

atively for surgical prophylaxis along with one dose of aztreonam
and vancomycin postoperatively for UTI. The patient returned a

DISCUSSION

year later with occluded right iliac stent with radiographic ﬁnd-

The presentation of UAF involves varying degrees of
hematuria, leading to difﬁcult diagnosis. History of intermittent hematuria lasting days to weeks is not uncommon before massive hematuria.10 Flank or back pain
secondary to ureter distention has also been described.11
Risk factors of UAF include pelvic surgery, radiation therapy, chronic ureteral stents1,12 (with chronic ureteral
stents being the most common in 73.7% of patients7),

ings concerning for graft infection and severe acute bleeding
from the right percutaneous nephrostomy tube. A Gore Viabahn
VBX 11-mm  7.9-cm stent graft was placed and ballooned
proximally with 18F complete seal of the right iliac system. The
patient was discharged with treatment for obstructive pyelonephritis of E. faecalis, Proteus, and Clostridium difﬁcile. Oral zyvox
and ciproﬂoxacin were prescribed for 2 weeks, followed by oral
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Table. Summary and outcomes of case reports
Patient
1

Indication
70-year-old woman
with history of
bilateral ureteral
strictures and
previous repair of
right UAF

Site
Left UAF

Procedure
d

d

Coil embolized right
iliac
8-  50-mm Viabahn
stent across defect

Antibiotics and
antifungals

Outcome
Successful repair

d

d

d

2

77-year-old woman
with history of
pelvic irradiation
and bilateral
ureteral strictures

Right UAF

d
d

Coil embolized
16-mm  12-mm
 7-cm
Viabahn endograft

Successful repair

d

d

d

3

58-year-old woman
with history of
pelvic irradiation

Right UAF

4

58-year-old woman
with history of
pelvic irradiation

Right iliac
to right
ureteral

d

d

Successful repair

d

Data not available

9-mm  10-cm
Viabahn stent graft
in right common
iliac and external

Successful repair

d

14-day anidulafungin
treatment
(pyelonephritis)
7-day oral
trimethoprimsulfamethoxazole (Bactrim) treatment
IV clindamycin
(preoperatively)
IV vancomycin (postoperative UTI)
IV aztreonam (postoperative UTI)
Discharged with 14-day
oral zyvox and ciproﬂoxacin prescription
Lifelong trimethoprimsulfamethoxazole

d

d

d

d

d

57-year-old man with
history of colon
cancer with
hematuria through
nephrostomyurostomy into ileal
conduit

Left UAF

d

d

d

28-day ertapenem
treatment (UTI)
14-day daptomycin
treatment (postoperative infection)
14-day ﬂuconazole
treatment (postoperative infection)

5-  22-mm Atrium
iCast stent graft

d

5

Discharged with oral
ciproﬂoxacin lifelong
prescription (UTI
prophylaxis)
IV ciproﬂoxacin
(preoperatively)
IV vancomycin
(preoperatively)

Multiple coil embolizations and stent
grafts
Right common
femoral to left
femoral bypass
Plugging the left
common femoral
and amputating
the external femoral
artery

Tolerated
procedure well
Returned
2 months later
with
gastrointestinal
bleeding
Arteriogram
showed bleed
from left iliac
artery stump
Death

d

Trimethoprim-sulfamethoxazole (UTI
preoperatively)

IV, Intravenous; UAF, ureteroarterial ﬁstula; UTI, urinary tract infection.

and history of malignant disease (cervical, bladder, and
colorectal). Abdominal and pelvic operations were reported in 69.5% of patients, including urinary diversion
in 30% of patients. Pelvic irradiation and vascular disease
were found in 48.3% and 41.5% of patients, respectively.7
The patients described herein had many of these risk

factors. Angiography can diagnose UAF and allow rapid
deployment of an endovascular stent graft with or
without coil embolization of the affected vasculature,12
and cystoscopy can determine laterality of the UAF7 by
showing which ureteral oriﬁce from the bladder is
bleeding. Ureteroscopy allows direct visualization of the
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Fig 2. A, Extravasation of contrast material from the external iliac artery into the ureter. B, Balloon inﬂated in the
ureter to tamponade the bleeding. C, Stent graft placed in the external iliac artery. D, No further extravasation
into the ureter after stent graft placement.

Fig 3. A, Preoperative computed tomography scan showing infected right iliac stent graft. B, Angiogram
showing occluded right common iliac and external iliac arteries, with contrast material ﬁlling the infected
proximal open portion of the right common iliac artery. C, After deployment of VBX stent graft, the
proximal part of the stent was ballooned to ﬁt the aorta and to exclude the right common iliac origin. D,
Completion angiogram. E, Postoperative computed tomography scan showing exclusion of the right
common iliac origin.
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Fig 4. A and B, Infection after placement of Amplatzer plug, ligation of distal external iliac artery, and femoralfemoral bypass with vein. C, Infected endograft after embolization. D and E, Final rupture that led to the patient’s death.

lesion. Pelvic angiography remains the diagnostic
method of choice, offering an immediate treatment
strategy.13-15 In cases of uncontrollable hematuria with
hemodynamic compromise, endovascular therapy is a
lifesaving measure.14,16
The potential pitfalls of this procedure include infection, stent thrombosis, and distal embolization. There
are no standard guidelines for antibiotic prophylaxis in
patients with UAF, but our recommendations are based
on review of the literature and the authors’ experience.
It is important to consider the patient’s medical condition and ability to undergo a high-risk procedure. In a
case report by Wang et al,16 the patient described with
an infected aortic endograft underwent washout, was
prescribed lifelong antibiotics, and was observed for
nearly 2 years after intervention. In another case report
by Gharacholou et al,17 the authors explained that
although long-term suppressive antimicrobial therapy
for infected endovascular stents has been used, patients
with persistent bacteremia or complications from the
infected stent may require explantation, and this is
currently the standard of care for infected endografts.

A retrospective chart review from 1975 to 2004
described three of eight patients with UAF treated with
endovascular stent graft. The authors recommended
chronic antibacterial prophylaxis to prevent infection of
the stent graft.18 Infection may also be due to chronic
indwelling ureteral stents. Two of the ﬁve patients herein
described developed infection after stent graft repair.
Uroprophylaxis with broad-spectrum antibiotics and antiplatelet therapy are preferred in one retrospective
review to avoid long-term lower extremity complications.19 One report described management of Klebsiella
pneumoniae with intravenous antibiotics and a 6-week
course of oral antibiotics20 shortly after stent graft placement for treatment of a UAF. Kirksey et al21 suggested
that a course of postoperative antibiotics should not
exceed 24 hours following the uncomplicated case of
endovascular stent graft placement. Exceptions to this
recommendation include cases requiring prolonged
use of indwelling catheters and intravenous lines, which
may require a longer course of antibiotics on the basis of
clinical judgment. Ferrar et al22 also considered the use
of prophylactic antibiotics in stent graft procedures.
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Although there is no established consensus for prophylactic antibiotics in patients with UAF and stent graft
treatment, we recommend that patients receive antibiotics for 6 weeks after the procedure, and in most cases,
depending on the surgeon’s discretion, lifelong antibiotics may not be unreasonable. In cases in which the
stent grafts become infected, the standard of care
should be to remove the foreign body and to perform
an extra-anatomic bypass, taking the patient’s general
medical condition into account.

CONCLUSIONS
UAF is a rare condition, but its incidence is increasing.23
UAF should be in the differential diagnosis of patients
with hematuria, urinary retention, fever, and pain.9,19
Endovascular therapy is a minimally invasive option that
is preferred in these patients secondary to the hostile nature of the open operative ﬁeld. Infection, secondary to repetitive ureteral manipulation, is a dangerous
complication, and antibiotic therapy is recommended.
Further studies are required to determine the optimal
course of antibiotics. No long-term follow-up has been
published to assess the possible complications arising
from the technique, such as prosthetic infection, nor
have antibiotic treatment protocols been established;
thus, long-term follow-up is necessary to determine late
complications of endovascular management of UAFs.24
We would like to acknowledge Jennifer Brumbaugh for
creating and editing the ureteroarterial ﬁstula image
(Fig 1) for this case report.
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